Arden Haslett

FDA Approves Ustekinumab Biosimilar Otulfi

October 1, 2024

The US Food and Drug Administration has approved ustekinumab-aauz (Otulfi), a biosimilar that references Johnson & Johnson's ustekinumab (Stelara).This is...

Arden Haslett

FDA Approves Ustekinumab Biosimilar Otulfi

FluoGuide submits clinical trial application for head and neck cancer treatment

Scottish patients first in UK to access new lung cancer treatment

‘Physician Spending Is Not the Problem in Healthcare’: What We Heard This Week

Machine learning model can diagnose Meniere disease

Rwanda will deploy Marburg vaccine under trial as death toll rises to 12

Novartis receives FDA accelerated approval for Fabhalta® (iptacopan)

Researchers develop ‘magnetic vine robots’ to transform cancer treatment

Study reveals AI insights can predict development of disease a decade in advance

Unsanitary conditions lead to recall of cornbread muffins

Technology strategy for success in value-based care

FluoGuide submits clinical trial application for head and neck cancer treatment

Scottish patients first in UK to access new lung cancer treatment

‘Physician Spending Is Not the Problem in Healthcare’: What We Heard This Week

Machine learning model can diagnose Meniere disease

Rwanda will deploy Marburg vaccine under trial as death toll rises to 12

About PhaMed

Recent News

You may have missed

About PhaMed

Recent News

Categories